Honggui Xu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study.
Journal: Annals of hematology
Published: December 29, 2025
Identification of a Patient with Transfusion-Dependent β-Thalassemia Caused by Compound Heterozygous Mutations of HBB: C.84_85insC and Common Linked Intronic Variants in HBB.
Journal: Hemoglobin
Published: December 11, 2025
Clinical patterns of thalidomide in the treatment of transfusion-dependent β-thalassaemia in children: a prospective single-arm study in China.
Journal: Annals of medicine
Published: October 11, 2025
Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia.
Journal: Cancer medicine
Published: September 17, 2025
A Chinese pediatric patient with thalassemia traits and compound heterozygous mutations in the PIEZO1 gene suspected of having dehydrated hereditary stomatocytosis.
Journal: Hematology (Amsterdam, Netherlands)
Published: May 05, 2025
Exploring the therapeutic effects of intensified immunosuppressive regimen for preengraftment syndrome after umbilical cord blood transplantation.
Journal: Clinical and experimental medicine
Published: April 27, 2025
Diagnosis and treatment of Diamond-Blackfan anemia and Pierre-Robin sequence caused by a novel mutation of RPS28 gene.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 26, 2025
Real-World Presentation and Prognostic Effect of Allogeneic Blood Transfusion during the Intensive Induction Phase in Pediatric Acute Lymphoblastic Leukemia.
Journal: Cancers
Published: August 05, 2023
Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia.
Journal: BMC cancer
Published: May 09, 2023
3CLpro inhibitors: DEL-based molecular generation.
Journal: Frontiers in pharmacology
Published: October 31, 2022
Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group.
Journal: Cancer medicine
Published: September 22, 2022
Discovery of TIGIT inhibitors based on DEL and machine learning.
Journal: Frontiers in chemistry
Published: June 30, 2022
Last Updated: 09/26/2026